Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pearson

Showing results (971-980 of 1,112) with videos related to

Pageof 112
Sort By:
Diabetologia|January 12, 2019
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational studyStuart J McGurnaghan, Liam Brierley, Thomas M Caparrotta, et al.
Journal of Addiction Medicine|October 16, 2020
Can Individuals With Alcohol Use Disorder Sustain Non-abstinent Recovery? Non-abstinent Outcomes 10 Years After Alcohol Use Disorder TreatmentKatie Witkiewitz, Adam D Wilson, Corey R Roos, et al.
The Lancet. Digital Health|November 25, 2022
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort studyJohn M Dennis, Katherine G Young, Andrew P McGovern, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 3, 2021
Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS RegisterAfagh Garjani, Rachael Hunter, Graham R Law, et al.
Diabetes Care|April 5, 2020
Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM TrialJagdeep S S Singh, Ify R Mordi, Keeran Vickneson, et al.
Communications Medicine|October 4, 2023
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic reviewKatherine G Young, Eram Haider McInnes, Robert J Massey, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysisKaixin Zhou, Louise Donnelly, Jian Yang, et al.
Diabetologia|March 5, 2022
Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell functionMoneeza K Siddiqui, Ranjit Mohan Anjana, Adem Y Dawed, et al.
Nature Communications|April 25, 2019
The extracellular matrix protects Bacillus subtilis colonies from Pseudomonas invasion and modulates plant co-colonizationCarlos Molina-Santiago, John R Pearson, Yurena Navarro, et al.
Kidney International|April 5, 2003
Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutationCoralie Bingham, Sian Ellard, William G van't Hoff, et al.
Pageof 112

Showing results (971-980 of 1,112) with videos related to

Sort By:
Pageof 112
Diabetologia|January 12, 2019
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational studyStuart J McGurnaghan, Liam Brierley, Thomas M Caparrotta, et al.
Journal of Addiction Medicine|October 16, 2020
Can Individuals With Alcohol Use Disorder Sustain Non-abstinent Recovery? Non-abstinent Outcomes 10 Years After Alcohol Use Disorder TreatmentKatie Witkiewitz, Adam D Wilson, Corey R Roos, et al.
The Lancet. Digital Health|November 25, 2022
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort studyJohn M Dennis, Katherine G Young, Andrew P McGovern, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 3, 2021
Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS RegisterAfagh Garjani, Rachael Hunter, Graham R Law, et al.
Diabetes Care|April 5, 2020
Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM TrialJagdeep S S Singh, Ify R Mordi, Keeran Vickneson, et al.
Communications Medicine|October 4, 2023
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic reviewKatherine G Young, Eram Haider McInnes, Robert J Massey, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysisKaixin Zhou, Louise Donnelly, Jian Yang, et al.
Diabetologia|March 5, 2022
Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell functionMoneeza K Siddiqui, Ranjit Mohan Anjana, Adem Y Dawed, et al.
Nature Communications|April 25, 2019
The extracellular matrix protects Bacillus subtilis colonies from Pseudomonas invasion and modulates plant co-colonizationCarlos Molina-Santiago, John R Pearson, Yurena Navarro, et al.
Kidney International|April 5, 2003
Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutationCoralie Bingham, Sian Ellard, William G van't Hoff, et al.
Pageof 112